Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cellvizio I.V.E. system with Confocal Miniprobes

K-Number: K212322 · 2021-08-18

Decision Date2021-08-18
Product CodeOWN
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Cellvizio I.V.E. system with Confocal Miniprobes is a medical device manufactured by Mauna Kea Technologies. It received FDA 510(k) clearance on 2021-08-18 under approval number K212322. The device is classified under product code OWN. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cellvizio I.V.E. system with Confocal Miniprobes?

Cellvizio I.V.E. system with Confocal Miniprobes is a medical device that received FDA 510(k) clearance on 2021-08-18. It is manufactured by Mauna Kea Technologies. The 510(k) number is K212322.

When was Cellvizio I.V.E. system with Confocal Miniprobes approved by the FDA?

Cellvizio I.V.E. system with Confocal Miniprobes received FDA 510(k) clearance on 2021-08-18, under approval number K212322.

What company makes Cellvizio I.V.E. system with Confocal Miniprobes?

Cellvizio I.V.E. system with Confocal Miniprobes is manufactured by Mauna Kea Technologies.

What is the FDA product code for Cellvizio I.V.E. system with Confocal Miniprobes?

The FDA product code for Cellvizio I.V.E. system with Confocal Miniprobes is OWN.

Related Clinical Trials

Other Devices by Mauna Kea Technologies

View all 9 devices →

Related Devices (Code: OWN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.